340B Payment Reductions in the CY2018 Final OPPS Rule

Nov 2, 2018
The Centers for Medicare & Medicaid Services today issued its calendar year 2019 outpatient prospective payment and ambulatory surgical center final rule, which updates hospital OPPS rates by 1.35 percent in CY 2019 compared to CY 2018.
Nov 30, 2021
With a few hours to digest this morning’s oral argument in American Hospital Association v. Becerra, I wanted provide a few high-level reactions.
Nov 29, 2021
The Supreme Court of the United States Nov. 30 will hear oral arguments in a case brought by the AHA and others asking the court to reverse the 2020 federal appeals court decision that upheld the authority of the Department of Health and Human Services to significantly cut payments to certain…
Nov 20, 2021
The government does not dispute that the agency singled out Section 340B hospitals as a group and set their reimbursement based on acquisition cost rather than price, without conducting the cost study that the statute requires. The agency’s action was therefore contrary to law.
Sep 3, 2021
The AHA urged The Supreme Court of the United States to reverse the 2020 federal appeals court decision that upheld the authority of the Department of Health and Human Services to significantly cut payments to certain hospitals that participate in the 340B Drug Pricing Program.
Jul 2, 2021
The Supreme Court of the United States today decided to take up AHA’s petition asking to reverse a federal appeals court decision that significantly cuts payments to certain hospitals that participate in the 340B Drug Pricing Program, threatening access to care in communities. 
May 28, 2021
IN THE Supreme Court of the United States THE AMERICAN HOSPITAL ASSOCIATION, et al., Petitioners, v. XAVIER BECERRA, in his official capacity as the Secretary of Health and Human Services, et al., Respondents. On Petition for a Writ of Certiorari to the United States Court of Appeals for the…
Mar 15, 2021
Learn what the HHS 340B Drug Pricing Program is and what 340B hospitals are. The program allows 340B hospitals to stretch limited federal resources to reduce the price of outpatient pharmaceuticals for patients by providing 340B drug pricing discounts and expand health services to the patients and…